Efficacy of chemotherapy and palliative hypofractionated radiotherapy for cats with nasal lymphoma

化疗和姑息性低分割放射治疗对患有鼻淋巴瘤的猫的疗效

阅读:6
作者:Maho Nakazawa, Hirotaka Tomiyasu, Kanako Suzuki, Hajime Asada, Aki Fujiwara-Igarashi, Yuko Goto-Koshino, Aki Ohmi, Koichi Ohno, Michio Fujita, Hajime Tsujimoto

Abstract

Nasal lymphoma (NL) is the most common nasal tumor in cats, and radiotherapy, chemotherapy, or a combination of these treatments have been described as the treatment for this disease. However, the previous studies included various machines and protocols of radiotherapy. Therefore, we aimed to retrospectively compare the prognosis among cases treated with palliative hypofractionated radiotherapy, chemotherapy, and a combination of them with united machine and protocol of radiotherapy. When compared overall survival and progression free survival, there was no significant difference among these three groups. The data of this study suggested that similar efficacy could be achieved by palliative hypofractionated radiotherapy, chemotherapy, or a combination of them.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。